“Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer: ALK5 inhibitor suppressed radiation induced metastasis”, Radiol Oncol, vol. 56, no. 2, pp. 185–197, Jul. 2022, Accessed: Jul. 30, 2026. Available: https://www.ojstest.computing.si/index.php/ro/article/view/3779